^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CYAD-101

i
Other names: CYAD-101, non-gene edited allogeneic CAR-T, TIM8-CYAD-01
Company:
Celyad Oncology
Drug class:
NKG2DL-targeted CAR-T immunotherapy